Biotech Medics Ne Stock Market Value

BMCS Stock  USD 0.01  0.0001  1.33%   
Biotech Medics' market value is the price at which a share of Biotech Medics trades on a public exchange. It measures the collective expectations of Biotech Medics Ne investors about its performance. Biotech Medics is selling for under 0.0074 as of the 9th of February 2026; that is 1.33 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0067.
With this module, you can estimate the performance of a buy and hold strategy of Biotech Medics Ne and determine expected loss or profit from investing in Biotech Medics over a given investment horizon. Check out Biotech Medics Correlation, Biotech Medics Volatility and Biotech Medics Performance module to complement your research on Biotech Medics.
Symbol

It's important to distinguish between Biotech Medics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biotech Medics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biotech Medics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Biotech Medics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotech Medics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotech Medics.
0.00
11/11/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/09/2026
0.00
If you would invest  0.00  in Biotech Medics on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Biotech Medics Ne or generate 0.0% return on investment in Biotech Medics over 90 days. Biotech Medics is related to or competes with Procyon. BioTech Medics, Inc. operates as a medical-based holding company More

Biotech Medics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotech Medics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotech Medics Ne upside and downside potential and time the market with a certain degree of confidence.

Biotech Medics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotech Medics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotech Medics' standard deviation. In reality, there are many statistical measures that can use Biotech Medics historical prices to predict the future Biotech Medics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biotech Medics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.017.53
Details
Intrinsic
Valuation
LowRealHigh
0.000.017.53
Details

Biotech Medics February 9, 2026 Technical Indicators

Biotech Medics Ne Backtested Returns

Biotech Medics Ne secures Sharpe Ratio (or Efficiency) of -0.0672, which signifies that the company had a -0.0672 % return per unit of risk over the last 3 months. Biotech Medics Ne exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotech Medics' Risk Adjusted Performance of 0.0262, downside deviation of 13.65, and Mean Deviation of 2.23 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.22, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biotech Medics will likely underperform. At this point, Biotech Medics Ne has a negative expected return of -0.14%. Please make sure to confirm Biotech Medics' treynor ratio and the relationship between the semi variance and price action indicator , to decide if Biotech Medics Ne performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.85  

Very good predictability

Biotech Medics Ne has very good predictability. Overlapping area represents the amount of predictability between Biotech Medics time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotech Medics Ne price movement. The serial correlation of 0.85 indicates that around 85.0% of current Biotech Medics price fluctuation can be explain by its past prices.
Correlation Coefficient0.85
Spearman Rank Test0.29
Residual Average0.0
Price Variance0.0

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Biotech Pink Sheet Analysis

When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.